Literature DB >> 14847103

Investigation of the cultivation of pleuropneumonia-like organisms from man.

H E MORTON, P F SMITH, P R LEBERMAN.   

Abstract

Entities:  

Keywords:  BACTERIA

Mesh:

Year:  1951        PMID: 14847103

Source DB:  PubMed          Journal:  Am J Syph Gonorrhea Vener Dis        ISSN: 0096-6738


× No keyword cloud information.
  22 in total

Review 1.  COMPARATIVE PHYSIOLOGY OF PLEUROPNEUMONIA-LIKE AND L-TYPE ORGANISMS.

Authors:  P F SMITH
Journal:  Bacteriol Rev       Date:  1964-06

Review 2.  MYCOPLASMA SPECIES OF MAN.

Authors:  L HAYFLICK; R M CHANOCK
Journal:  Bacteriol Rev       Date:  1965-06

3.  Culture and metabolism of Mycoplasma gallisepticum.

Authors:  J W GILL
Journal:  J Bacteriol       Date:  1962-02       Impact factor: 3.490

4.  Amino acid metabolism by pleuropneumonialike organisms. I. General catabolism.

Authors:  P F SMITH
Journal:  J Bacteriol       Date:  1955-11       Impact factor: 3.490

5.  Stability of pleuropneumonialike organisms to some physical factors.

Authors:  P F SMITH; S SASAKI
Journal:  Appl Microbiol       Date:  1958-05

6.  Lipid requirements for the growth of pleuropneumonia-like organisms.

Authors:  P F SMITH; R J LYNN
Journal:  J Bacteriol       Date:  1958-09       Impact factor: 3.490

7.  Quantitative measurement of the growth of pleuropneumonia-like organisms.

Authors:  P F SMITH
Journal:  Appl Microbiol       Date:  1956-09

8.  The inhibitory action of agar on certain strains of pleuropneumonia-like organisms.

Authors:  R J LYNN; H E MORTON
Journal:  Appl Microbiol       Date:  1956-11

9.  Electron microscope studies of pleuropneumonia like organisms isolated from man and chickens.

Authors:  H E MORTON; J C LECCE; J J OSKAY; N H COY
Journal:  J Bacteriol       Date:  1954-12       Impact factor: 3.490

10.  Growth inhibition of Mycoplasma by inhibitors of polyterpene biosynthesis and its reversal by cholesterol.

Authors:  P F Smith; C V Henrikson
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.